Literature DB >> 24898873

Gastrointestinal angiodysplasia and bleeding in von Willebrand disease.

M Franchini, P M Mannucci1.   

Abstract

Von Willebrand disease (VWD), the most common genetic bleeding disorder, is characterised by a quantitative or qualitative defect of von Willebrand factor (VWF). Patients with VWD suffer from mucocutaneous bleeding, of severity usually proportional to the degree of VWF defect. In particular, gastrointestinal bleeding associated with angiodysplasia is often a severe symptom of difficult management. This review focuses on the pathophysiology, diagnosis and treatment of VWD-associated gastrointestinal angiodysplasia and related bleeding.

Entities:  

Keywords:  bleeding; gastrointestinal angiodysplasia; therapy; von Willebrand disease

Mesh:

Substances:

Year:  2014        PMID: 24898873     DOI: 10.1160/TH13-11-0952

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Our findings differ.

Authors:  Bartosz Hudzik; Krzysztof Wilczek; Mariusz Gasior
Journal:  CMAJ       Date:  2015-10-20       Impact factor: 8.262

Review 2.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 3.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

Review 4.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  New therapies for von Willebrand disease.

Authors:  Pier Mannuccio Mannucci
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

6.  Arteriosclerosis Is a Major Predictor of Small Bowel Vascular Lesions.

Authors:  Taiki Aoyama; Akira Fukumoto; Kenjiro Shigita; Naoki Asayama; Shinichi Mukai; Shinji Nagata
Journal:  Dig Dis Sci       Date:  2018-01-25       Impact factor: 3.199

7.  New therapies for von Willebrand disease.

Authors:  Pier Mannuccio Mannucci
Journal:  Blood Adv       Date:  2019-11-12

8.  Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report.

Authors:  Racquel Brown
Journal:  Blood Coagul Fibrinolysis       Date:  2017-10       Impact factor: 1.276

Review 9.  Current and Emerging Options for the Management of Inherited von Willebrand Disease.

Authors:  Jessica M Heijdra; Marjon H Cnossen; Frank W G Leebeek
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

10.  Thalidomide for the Treatment of Gastrointestinal Bleeding Due to Angiodysplasia in a Patient with Glanzmann's Thrombasthenia.

Authors:  Bruno K L Duarte; Sílvia M de Souza; Carolina Costa-Lima; Samuel S Medina; Margareth C Ozelo
Journal:  Hematol Rep       Date:  2017-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.